Heartware (Framingham, Mass.) is stepping into new territory with its latest acquisition and branching out into the mitral valve replacement and repair market. The company, which is known solely for developing ventricular assist devices (VAD) said it would achieve this bold move by acquiring Valtech Cardio (Yehuda, Israel), a private company, in a deal some analysts estimate to be worth $425 million. Read More
